Traduction de «results from a systematic » (Néerlandais → Français) :

[5] C. Chaix-couturier, I. Durand-zaleski, D. Jolly, and P. Durieux, Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues, Sante, vol. 12, no. 2, pp.
[5] C. Chaix-couturier, I. Durand-zaleski, D. Jolly, and P. Durieux, Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issues, Sante, vol. 12, no. 2, pp. 133-142, 2000.

Income from associated companies The decline in income from associated companies in the first half of 2009 resulted mainly from reduced contributions from the Roche stake, which included a negative adjustment of USD 40 million since Roche’s reported 2008 results were lower than anticipated.
Résultat provenant des sociétés associées Le repli du résultat provenant des sociétés associées au premier semestre 2009 est dû essentiellement à une réduction des contributions issues de la participation dans Roche, qui incluaient un ajustement à la baisse d’USD 40 millions des résultats de Roche présentés en 2008, lesquels avaient été inférieurs aux attentes.

Considerable attention was focused in 2007 on increased cooperation on the part of the FAMHP with the ethics committees, with the following results: ●● An interactive website with a web application that makes possible the “simple” management of communication actions between the different ethics committees, the FAMHP, the sponsors and researchers, and also monitors the different stages in the evaluation of each application by the ethics committees ●● Systematic consultation for the more complex scientific applications ●● Further optimisation of the functioning of
Considerable attention was focused in 2007 on increased cooperation on the part of the FAMHP with the ethics committees, with the following results: ●● An interactive website with a web application that makes possible the “simple” management of communication actions between the different ethics committees, the FAMHP, the sponsors and researchers, and also monitors the different stages in the evaluation of each application by the ethics committees ●● Systematic consultation for the more complex scientific applications ●● Further optimisation of the functioning of

CORE RESULTS – Reconciliation from IFRS results to core results – Pharmaceuticals (unaudited)
RÉSULTATS CORE – Rapprochement des résultats IFRS des résultats core – Pharmaceuticals (non audités)

CORE RESULTS – Reconciliation from IFRS results to core results – Vaccines and Diagnostics (unaudited)
RÉSULTATS CORE – Rapprochement des résultats IFRS des résultats core – Vaccins et Diagnostic (non audités)

CORE RESULTS – Reconciliation from IFRS results to core results – Sandoz (unaudited)
RÉSULTATS CORE – Rapprochement des résultats IFRS des résultats core – Sandoz (non audités)

CORE RESULTS – Reconciliation from IFRS results to core results – Consumer Health (unaudited)
RÉSULTATS CORE – Rapprochement des résultats IFRS des résultats core – Consumer Health (non audités)

CORE RESULTS Reconciliation from IFRS results to core results – Group – First quarter 2010 (unaudited)
RÉSULTATS CORE Rapprochement des résultats IFRS des résultats core – Premier trimestre 2010 (non audité)

CORE RESULTS – Reconciliation from IFRS results to core results – Alcon, Inc (unaudited)
RÉSULTATS CORE – Rapprochement des résultats IFRS des résultats core – Alcon, Inc (non audités)

The medicine market itself determines the rate of inspections resulting from authorisation applications and variations.
The medicine market itself determines the rate of inspections resulting from authorisation applications and variations.